-+ 0.00%
-+ 0.00%
-+ 0.00%

Lifevantage Lowers FY2026 Adj EPS Guidance from $1.00-$1.15 to $0.60-$0.80 vs $1.05 Est; Lowers FY2026 Sales Guidance from $225.000M-$240.000M to $185.000M-$200.000M vs $227.507M Est

Benzinga·02/04/2026 21:08:41
Listen to the news
Lifevantage (NASDAQ:LFVN) lowers FY2026 Adj EPS guidance from $1.00-$1.15 to $0.60-$0.80 vs $1.05 analyst estimate. Lowers FY2026 sales outlook from $225.000 million-$240.000 million to $185.000 million-$200.000 million vs $227.507 million estimate.